- Home
- ORGO vs NX Comparison
ORGO vs NX Comparison
Compare ORGO & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- NX
- Stock Information
- Founded
- ORGO 1985
- NX 1927
- Country
- ORGO United States
- NX United States
- Employees
- ORGO N/A
- NX N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- NX Metal Fabrications
- Sector
- ORGO Health Care
- NX Industrials
- Exchange
- ORGO Nasdaq
- NX Nasdaq
- Market Cap
- ORGO 539.1M
- NX 599.2M
- IPO Year
- ORGO N/A
- NX N/A
- Fundamental
- Price
- ORGO $5.14
- NX $12.92
- Analyst Decision
- ORGO Buy
- NX
- Analyst Count
- ORGO 3
- NX 0
- Target Price
- ORGO $8.00
- NX N/A
- AVG Volume (30 Days)
- ORGO 3.1M
- NX 577.3K
- Earning Date
- ORGO 11-06-2025
- NX 12-11-2025
- Dividend Yield
- ORGO N/A
- NX 2.47%
- EPS Growth
- ORGO N/A
- NX N/A
- EPS
- ORGO N/A
- NX N/A
- Revenue
- ORGO $465,218,000.00
- NX $1,839,956,000.00
- Revenue This Year
- ORGO $2.51
- NX $46.73
- Revenue Next Year
- ORGO $25.45
- NX $0.48
- P/E Ratio
- ORGO N/A
- NX N/A
- Revenue Growth
- ORGO 2.24
- NX 70.18
- 52 Week Low
- ORGO $2.61
- NX $11.04
- 52 Week High
- ORGO $7.08
- NX $29.90
- Technical
- Relative Strength Index (RSI)
- ORGO 50.25
- NX 46.81
- Support Level
- ORGO $5.09
- NX $11.04
- Resistance Level
- ORGO $5.83
- NX $13.13
- Average True Range (ATR)
- ORGO 0.50
- NX 0.56
- MACD
- ORGO -0.08
- NX 0.12
- Stochastic Oscillator
- ORGO 3.02
- NX 75.71
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.